Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Pentamedix Co. Ltd. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 examiners and 3 art units, so prosecution management must account for multiple examination settings within the portfolio.
VASSELL, MEREDITH ABBOTT is the listed busiest examiner, with 1 pending matter. The distribution supports matter-specific response planning, while the VASSELL assignment provides one identifiable file for closer review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VASSELL, MEREDITH ABBOTT | 1 | 29.9% | +45.8% |
| SALMON, KATHERINE D | 1 | 42.9% | +37.7% |
| KALLAL, ROBERT JAMES | 1 | 59.4% | +31.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17791528 | METHOD AND SYSTEM FOR SCREENING NEOANTIGENS, AND USES THEREOF | VASSELL, MEREDITH ABBOTT | — |
| 17257206 | METHOD FOR PREDICTING RESPONSE TO ANTICANCER IMMUNOTHERAPY USING DNA METHYLATION ABERRATION | SALMON, KATHERINE D | — |
| 17625983 | MACHINE LEARNING MODEL-BASED ESSENTIAL GENE IDENTIFICATION METHOD AND ANALYSIS APPARATUS | KALLAL, ROBERT JAMES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17791528 | METHOD AND SYSTEM FOR SCREENING NEOANTIGENS, AND USES THEREOF | VASSELL, MEREDITH ABBOTT | — |
| 17257206 | METHOD FOR PREDICTING RESPONSE TO ANTICANCER IMMUNOTHERAPY USING DNA METHYLATION ABERRATION | SALMON, KATHERINE D | — |
| 17625983 | MACHINE LEARNING MODEL-BASED ESSENTIAL GENE IDENTIFICATION METHOD AND ANALYSIS APPARATUS | KALLAL, ROBERT JAMES | — |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| 1682 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17791528 | METHOD AND SYSTEM FOR SCREENING NEOANTIGENS, AND USES THEREOF | VASSELL, MEREDITH ABBOTT | 1687 | §103§112 | Final Rejection | — | Pending | Jul 07, 2022 |
| 17257206 | METHOD FOR PREDICTING RESPONSE TO ANTICANCER IMMUNOTHERAPY USING DNA METHYLATION ABERRATION | SALMON, KATHERINE D | 1682 | §101§103§112 | Final Rejection | — | Pending | Mar 07, 2022 |
| 17625983 | MACHINE LEARNING MODEL-BASED ESSENTIAL GENE IDENTIFICATION METHOD AND ANALYSIS APPARATUS | KALLAL, ROBERT JAMES | 1685 | §101 | Final Rejection | — | Pending | Jan 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPentamedix Co. Ltd. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Meredith Abbott Vassell has the most, with 1 of Pentamedix Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
